Page 102 - 南京医科大学自然版

第44卷第10期
·1418 · 南 京 医 科 大 学 学 报 2024年10月

genin［J］. J Cancer，2019，10（14）：3197-3207 of central nerve system metastases from non ⁃ small cell
［56］JURCAK N R，RUCKI A A，MUTH S，et al. Axon guid⁃ lung cancer［J］. Cancer Lett，2014，351（1）：6-12
ance molecules promote perineural invasion and metasta⁃ ［65］FALCINELLI M，AL⁃HITY G，BARON S，et al. Proprano⁃
sis of orthotopic pancreatic tumors in mice［J］. Gastroen⁃ lol reduces IFN⁃γ driven PD⁃L1 immunosuppression and
terology，2019，157（3）：838-850 improves anti ⁃ tumour immunity in ovarian cancer［J］.
［57］CAPPARUCCIA L，TAMAGNONE L. Semaphorin signal⁃ Brain Behav Immun，2023，110：1-12
ing in cancer cells and in cells of the tumor microenviron⁃ ［66］KOH M，TAKAHASHI T，KUROKAWA Y，et al. Propran⁃
ment ⁃ two sides of a coin［J］. J Cell Sci，2009，122（Pt olol suppresses gastric cancer cell growth by regulating
11）：1723-1736 proliferation and apoptosis［J］. Gastric Cancer，2021，24
［58］NISHI K，SUZUKI M，YAMAMOTO N，et al. Glutamine （5）：1037-1049
deprivation enhances acetyl⁃CoA carboxylase inhibitor⁃in⁃ ［67］HOPSON M B，LEE S，ACCORDINO M，et al. Phase Ⅱ
duced death of human pancreatic cancer cells［J］. Anti⁃ study of propranolol feasibility with neoadjuvant chemo⁃
cancer Res，2018，38（12）：6683-6689 therapy in patients with newly diagnosed breast cancer［J］.
［59］GÖHRIG A，DETJEN K M，HILFENHAUS G，et al. Axon Breast Cancer Res Treat，2021，188（2）：427-432
guidance factor SLIT2 inhibits neural invasion and metas⁃ ［68］ZHOU S，LI J B，YU J，et al. Tumor microenvironment ad⁃
tasis in pancreatic cancer［J］. Cancer Res，2014，74（5）： renergic nerves blockade liposomes for cancer therapy［J］.
1529-1540 J Control Release，2022，351：656-666
［60］HARBURG G C，HINCK L. Navigating breast cancer：ax⁃ ［69］UDUMYAN R，MONTGOMERY S，FANG F，et al. Beta⁃
on guidance molecules as breast cancer tumor suppres⁃ blocker drug use and survival among patients with pancre⁃
sors and oncogenes［J］. J Mammary Gland Biol Neopla⁃ atic adenocarcinoma［J］. Cancer Res，2017，77（13）：
sia，2011，16（3）：257-270 3700-3707
［61］ADRIAENSSENS E，VANHECKE E，SAULE P，et al. ［70］DIAZ E S，KARLAN B Y，LI A J. Impact of beta blockers
Nerve growth factor is a potential therapeutic target in on epithelial ovarian cancer survival［J］. Gynecol Oncol，
breast cancer［J］. Cancer Res，2008，68（2）：346-351 2012，127（2）：375-378
［62］BAPAT A A，MUNOZ R M，VON HOFF D D，et al. Block⁃ ［71］HE D D，MANZONI A，FLORENTIN D，et al. Biologic
ing nerve growth factor signaling reduces the neural inva⁃ effect of neurogenesis in pancreatic cancer［J］. Hum
sion potential of pancreatic cancer cells［J］. PLoS One， Pathol，2016，52：182-189
2016，11（10）：e0165586 ［72］KARSENTY G，ROCHA J，CHEVALIER S，et al. Botuli⁃
［63］HEFTI F. Pharmacology of nerve growth factor and discov⁃ num toxin type A inhibits the growth of LNCaP human
ery of tanezumab，an anti⁃nerve growth factor antibody and prostate cancer cells in vitro and in vivo［J］. Prostate，
pain therapeutic［J］. Pharmacol Res，2020，154：104240 2009，69（11）：1143-1150
［64］ZHANG J Z，YU J M，SUN X D，et al. Epidermal growth ［收稿日期］ 2024-04-29
factor receptor tyrosine kinase inhibitors in the treatment （本文编辑：陈汐敏）